Home/Pipeline/iNCOVACC

iNCOVACC

COVID-19 Prevention

CommercialAuthorized

Key Facts

Indication

COVID-19 Prevention

Phase

Commercial

Status

Authorized

Company

Bharat Biotech

About Bharat Biotech

A pioneering Indian biotech company developing and manufacturing innovative, affordable vaccines for infectious diseases, with over 2 billion doses delivered globally.

View full company profile

Therapeutic Areas

Infectious Disease

Other COVID-19 Prevention Drugs

Drug	Company	Phase	Status
Intranasal COVID Vaccine	Virpax Pharmaceuticals	Research	Exploratory
COVID-19 Vaccine Trials	DM Clinical Research	Not Specified	Active
SARS-CoV-2 Vaccine	Epygen Biotech	Not Disclosed	Active
COVAXIN	Bharat Biotech	Commercial	Authorized
IRT Platform (e.g., COVID-19)	Biological Mimetics	Research/Pre-clinical	Active
Replicon RNA COVID-19 Vaccine	BIKEN Group	Preclinical/Development	Partnership Development with VLPT Japan
Convidecia Air® (XBB.1.5 Variant)	CanSino Biologics	Approved	Marketed
COVID-19 Vaccine	Recbio Technology	Not specified	Active
COMIRNATY® (BNT162b2)	Fosun Pharma	Approved	Commercial in HK/Macao
BBIBP-CorV	Sinopharm	Approved	Marketed
Recombinant Protein COVID-19 Vaccine	Sinopharm	Approved	Marketed
COVID-19 mRNA Vaccine (SYS6006)	CSPC Innovation Pharmaceutical	Marketed	Conditional Approval